Is Johnson & Johnson (JNJ) The Most Profitable Healthcare Stock To Buy?

4 days ago 3

Rameen Kasana

Sat, January 31, 2026 astatine 11:35 AM CST 1 min read

Johnson & Johnson (NYSE:JNJ) is among the most profitable healthcare stocks to buy. On January 22, TD Cowen lifted the terms people connected Johnson & Johnson (NYSE:JNJ) to $250, up from $222, and maintained a Buy rating, citing the company’s 4th fourth results. The revised terms people reflects an upside imaginable of astir 14%.

According to the firm, the archetypal projection of Johnson & Johnson (NYSE:JNJ) should uplift the statement gross and EPS forecasts for the healthcare powerhouse. From this twelvemonth and beyond, the company’s Pharmaceutical and Medical Devices franchises are expected to proceed their maturation trajectory, TD Cowen noted.

Jim Cramer Couldn't Stop Gushing About Johnson & Johnson (JNJ)'s Cancer Drugs

Trong Nguyen / Shutterstock.com

On the aforesaid day, respective different analysts updated their outlooks to amended bespeak the company’s Q4 performance, which exceeded marketplace estimates with $24.6 cardinal successful revenue. BofA Securities besides somewhat raised its terms people connected Johnson & Johnson (NYSE:JNJ) from $220 to $221 and reiterated a Neutral standing connected the stock. The company’s fiscal results were described arsenic “solid” by the firm, which attributes it to the maturation drivers, peculiarly currency movements.

Johnson & Johnson (NYSE:JNJ), headquartered successful New Jersey, offers healthcare products worldwide. Founded successful 1886, the institution operates successful 2 main segments: Innovative Medicine and MedTech.

While we admit the imaginable of JNJ arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.